Person profile
Address
Waltham, Massachusetts
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
ALUMIS INC.
3 Jul 24
3
ALUMIS INC.
27 Jun 24
4
Aura Biosciences, Inc.
9 Nov 23
4
Zentalis Pharmaceuticals, Inc.
20 Jun 23
4
ACELYRIN, Inc.
11 May 23
3
ACELYRIN, Inc.
4 May 23
4
Aura Biosciences, Inc.
7 Dec 22
3
Zentalis Pharmaceuticals, Inc.
3 Jun 22
4
Aura Biosciences, Inc.
4 Nov 21
3
Aura Biosciences, Inc.
28 Oct 21
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
1 Jul 24 | ALMS Alumis Inc. Common Stock | Common Stock | Grant | Acquire A | Yes | No | 16 | 2,500,000 | 40.00 mm | 10,645,966 |
1 Jul 24 | ALMS Alumis Inc. Common Stock | Common Stock, par value $0.0001 per share ("Common Stock") | Conversion | Acquire C | Yes | No | 0 | 8,145,966 | 0.00 | 8,145,966 |
1 Jul 24 | ALMS Alumis Inc. Common Stock | Series C Redeemable Convertible Preferred Stock Common Stock | Conversion | Dispose C | Yes | No | 0 | 12,745,916 | 0.00 | 0 |
1 Jul 24 | ALMS Alumis Inc. Common Stock | Series B-2 Redeemable Convertible Preferred Stock Common Stock | Conversion | Dispose C | Yes | No | 0 | 5,336,489 | 0.00 | 0 |
1 Jul 24 | ALMS Alumis Inc. Common Stock | Series B Redeemable Convertible Preferred Stock Common Stock | Conversion | Dispose C | Yes | No | 0 | 20,000,000 | 0.00 | 0 |
9 Nov 23 | AURA Aura Biosciences | Common Stock, par value $0.00001 per share (Common Stock) | Buy | Acquire P | Yes | No | 9 | 1,560,000 | 14.04 mm | 6,922,870 |
20 Jun 23 | ZNTL Zentalis Pharmaceuticals | Common Stock, par value $0.001 per share | Buy | Acquire P | Yes | No | 22.66 | 4,760,000 | 107.86 mm | 13,959,973 |
9 May 23 | SLRN Acelyrin | Common Stock, par value $0.00001 per share ("Common Stock") | Conversion | Acquire C | Yes | No | 0 | 9,334,735 | 0.00 | 9,334,735 |
9 May 23 | SLRN Acelyrin | Series C Redeemable Convertible Preferred Stock Common Stock | Conversion | Dispose C | Yes | No | 0 | 3,709,429 | 0.00 | 0 |
9 May 23 | SLRN Acelyrin | Series B Redeemable Convertible Preferred Stock Common Stock | Conversion | Dispose C | Yes | No | 0 | 5,625,306 | 0.00 | 0 |